Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001847903-24-000167
Filing Date
2024-11-12
Accepted
2024-11-12 07:16:41
Documents
67
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnta-20240930.htm   iXBRL 10-Q 1617311
2 EX-31.1 a20240930exhibit311.htm EX-31.1 9302
3 EX-31.2 a20240930exhibit312.htm EX-31.2 9219
4 EX-32.1 a20240930exhibit321.htm EX-32.1 5256
5 EX-32.2 a20240930exhibit322.htm EX-32.2 5062
11 GRAPHIC cnta-20240930_g1.jpg GRAPHIC 69799
12 GRAPHIC cnta-20240930_g2.jpg GRAPHIC 130491
  Complete submission text file 0001847903-24-000167.txt   7109480

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20240930.xsd EX-101.SCH 37271
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cnta-20240930_cal.xml EX-101.CAL 64162
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20240930_def.xml EX-101.DEF 223800
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20240930_lab.xml EX-101.LAB 601896
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20240930_pre.xml EX-101.PRE 404946
69 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20240930_htm.xml XML 703777
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40445 | Film No.: 241443255
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)